文献速递神经肿瘤

眶上额下经终板内镜辅助入路治疗第三脑室后部肿瘤

Supraorbital subfrontal trans-laminar endoscope-assisted approach for tumors of the posterior third ventricle.
PubMed 文献 · Acta Neurochir (Wien) · 2017-02-24

该研究纳入7例第三脑室后部肿瘤患者,采用眶上额下经终板内镜辅助入路手术,其中4例同期经相同入路行常规第三脑室造瘘。4例全切、2例次全切、1例仅活检;除1例胶质母细胞瘤活检后瘤内出血延迟放化疗外无重大并发症,随访平均39.57个月(范围13-85个月)无需脑室腹腔分流。作者认为该入路在选定病例中可能安全有效。

要点

  • 7例第三脑室后部肿瘤采用眶上额下经终板内镜辅助入路,4例全切、2例次全切、1例活检。
  • 4例经相同经终板入路行常规第三脑室造瘘。
  • 随访平均39.57个月(范围13-85个月),无需脑室腹腔分流。

核心结论

  • 眶上额下经终板内镜辅助入路在选定病例中可能为处理第三脑室后部肿瘤提供高效且安全的路径。

研究设计与样本

  • 本研究为病例系列,纳入7例第三脑室后部肿瘤患者,采用眶上额下经终板内镜辅助入路手术。

主要发现

  • 7例肿瘤包括2例颅咽管瘤、1例松果体区乳头状肿瘤、1例松果体细胞瘤、2例神经细胞瘤、1例胶质母细胞瘤。
  • 4例全切、2例次全切、1例仅活检;4例经相同经终板入路行常规第三脑室造瘘。
  • 术后除1例胶质母细胞瘤活检患者发生瘤内出血仅延迟辅助放化疗开始外,无重大并发症。
  • 最近一次临床和影像随访平均39.57个月(范围13-85个月),这些患者无需脑室腹腔分流。

关键数值与推荐

  • 根据组织学诊断需要时给予辅助放疗和/或化疗。

临床怎么用

  • 作者认为,眶上额下经终板内镜辅助入路在选定病例中可能为第三脑室后部肿瘤提供高效且安全的路径。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Different surgical approaches have been developed for dealing with third ventricle lesions, all aimed at obtaining a safe removal minimizing brain manipulation. The supraorbital subfrontal trans-lamina terminalis route, commonly employed only for the anterior third ventricle, could represent, in selected cases with endoscopic assistance, an alternative approach to posterior third ventricular lesions. METHODS: Seven patients underwent a supraorbital subfrontal trans-laminar endoscope-assisted approach to posterior third ventricle tumors (two craniopharyngiomas, one papillary tumor of the pineal region, one pineocytoma, two neurocytomas, one glioblastoma). Moreover, a conventional third ventriculostomy was performed via the same trans-laminar approach in four cases. RESULTS: Complete tumor removal was accomplished in four cases, subtotal removal in two cases, and a simple biopsy in one case. Adjuvant radiotherapy and/or chemotherapy was administered, if required, on the basis of the histologic diagnosis. No major complications occurred after surgery except for an intratumoral hemorrhage in a patient undergoing a biopsy for a glioblastoma, which simply delayed the beginning of adjuvant radiochemotherapy. No ventriculoperitoneal shunt placement was needed in these patients at the most recent clinical and radiologic session (average 39.57 months, range 13-85 months). Two illustrative cases are presented. CONCLUSIONS: The supraorbital subfrontal trans-laminar endoscope-assisted approach may provide, in selected cases, an efficient and safe route for dealing with posterior third ventricular tumors.

来源:Acta Neurochir (Wien),查看原文。版权归原作者所有。

引用

  1. Iacoangeli M, Colasanti R, Esposito D, et al. Supraorbital subfrontal trans-laminar endoscope-assisted approach for tumors of the posterior third ventricle. Acta Neurochir (Wien). 2017. PMID: 28236180. doi:10.1007/s00701-017-3117-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。